Emma Andrus, Editor

Michael Gold, MD, explored medical and procedural acne treatments and the emerging role of exosomes in regenerative dermatology.

Michael Gold, MD, shares why the South Beach Symposium remains a must-attend legacy event for dermatologists, blending education and innovation.

Study author Erin McClure, MD, discusses how IGSRT offers consistent NMSC recurrence rates across socioeconomic and comorbidity factors, reinforcing its role as a first-line treatment.

New RELAX trial data show Relfydess delivers rapid onset and 6-month efficacy.

This review of the latest dermatologic studies includes insights into the efficacy of nutraceuticals in noncystic acne, the role of antimicrobial peptides in the skin barrier, and more.

The clinically-backed, post-procedure sunscreen is designed to enhance skin healing, reduce redness, promote hydration, and provide broad-spectrum UV protection.

Dermatology Times has compiled a list of dermatological meetings taking place during the month of February.

Dermatology Times is looking back on the top stories in dermatology from the month of January.

Dermatology Times is recapping our top expert interviews from the month of January.

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.

Muhle shares Galderma's study results on Sculptra and Restylane, showcasing regenerative aesthetics and personalized HIT treatments.

A new study explores an effective treatment protocol to restore volume and improve skin quality in patients experiencing facial changes from weight loss medications.

Galderma's Gerry Muhle addresses facial aesthetic needs linked to weight loss, focusing on personalized, regenerative treatments.

George Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.

Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.

Attovia is also advancing 4 ATTOBODY-based programs for inflammatory conditions, such as atopic dermatitis and IBD.

Adam Friedman, MD, FAAD, takes a closer look at the emerging landscape of oral treatments for hyperhidrosis and what lies ahead in advancing patient care.

Cytrellis' new president and CEO discusses bridging surgery and innovation in aesthetics.

Ellacor 2.0 offers advanced micro-coring technology, streamlined protocols, and faster results for non-surgical skin rejuvenation.

Three posters supporting VP-315's treatment efficacy and outcomes were presented at the Winter Clinical Miami conference.

Share your thoughts and help shape our content by telling us what topics you want to see more of this year.

A recent study evaluated the efficacy of low-energy delicate pulsed light photomodulation for treating sensitive skin, showing significant improvements in symptoms and erythema.

Emerging noninvasive imaging technologies, particularly optical coherence tomography, offer a revolutionary approach to monitoring vitiligo treatment responses.

Soligenix recently shared interim results from a 12-month investigator-initiated study of synthetic hypericin.